These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26340462)

  • 1. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study.
    Moon AR; Choi DH; Jahng SY; Kim BB; Seo HJ; Kim SH; Ryu SW; Song H; Kim TH
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):70-6. PubMed ID: 26340462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: A comparable and additive study.
    Seo HJ; Ki YJ; Han MA; Choi DH; Ryu SW
    Platelets; 2015; 26(7):665-71. PubMed ID: 25383727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.
    Choi SW; Choi DH; Kim HW; Ku YH; Ha SI; Park G
    Platelets; 2014; 25(5):322-7. PubMed ID: 23909871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
    Ki YJ; Park S; Ha SI; Choi DH; Song H
    Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.
    Kim D; Choi DH; Kim BB; Choi SW; Park KH; Song H
    J Clin Lab Anal; 2016 Nov; 30(6):930-940. PubMed ID: 27075615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention.
    Wang XY; Yu HY; Zhang YY; Wang YP; Feng XH; Li ZP; Du XJ; Gao W
    Thromb Res; 2015 Apr; 135(4):652-8. PubMed ID: 25682433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization in left main coronary artery disease: comparison of off-pump coronary artery bypass grafting vs percutaneous coronary intervention.
    Jeong DS; Lee YT; Chung SR; Jeong JH; Kim WS; Sung K; Park PW
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):718-24. PubMed ID: 23423919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction.
    Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW
    Can J Cardiol; 2022 Jan; 38(1):92-101. PubMed ID: 34737035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
    J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention.
    Eisen A; Bental T; Assali A; Kornowski R; Lev EI
    J Thromb Thrombolysis; 2013 Nov; 36(4):469-74. PubMed ID: 23345043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Yuan D; Wang P; Jia S; Zhang C; Zhu P; Jiang L; Liu R; Xu J; Tang X; Song Y; Yao Y; Xu N; Zhang Y; Zhao X; Yang Y; Xu B; Gao L; Gao Z; Gao R; Yuan J
    Atherosclerosis; 2022 Dec; 363():109-116. PubMed ID: 36357218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Chen QJ; Yang YN; Ma YT; Li XM; Xu R; Zhai H; Liu F; Chen BD; Zhao Q
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):5-12. PubMed ID: 26258675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.